TY  - JOUR
AU  - Camblor, Daniel G
AU  - Miranda, Daniel
AU  - Albaiceta, Guillermo M
AU  - Amado-Rodríguez, Laura
AU  - Cuesta-Llavona, Elías
AU  - Vázquez-Coto, Daniel
AU  - Gómez de Oña, Julia
AU  - García-Lago, Claudia
AU  - Gómez, Juan
AU  - Coto, Eliecer
PY  - 2022
DO  - 10.1016/j.humimm.2022.06.002
UR  - http://hdl.handle.net/10668/22257
T2  - Human immunology
AB  - The NF-κB signaling pathway is a key regulator of inflammation in the response to SARS-CoV-2 infection. This pathway has been implicated in the hyperinflammatory state that characterizes the severe forms of COVID-19. The genetic variation of the NF-κB...
LA  - en
KW  - COVID-19
KW  - Gene polymorphisms
KW  - Genetic association
KW  - NF-κB signaling pathway
KW  - NFKBIZ
KW  - Adaptor Proteins, Signal Transducing
KW  - COVID-19
KW  - Genetic Association Studies
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - NF-KappaB Inhibitor alpha
KW  - NF-kappa B
KW  - NF-kappa B p50 Subunit
KW  - Polymorphism, Single Nucleotide
KW  - SARS-CoV-2
KW  - Signal Transduction
TI  - Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.
TY  - research article
VL  - 83
ER  -